Significance of vascular endothelial cell growth factor upregulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 3, 2002, Pages 949-956

  Katada, Jun ^a,d   Muramatsu, Michiko ^b   Hayashi, Izumi ^a   Tsutsumi, Masahiro ^c   Konishi, Yoichi ^e   Majima, Masataka ^a  

^a KITASATO UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d PCD Japan   (Japan)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; BASIC FIBROBLAST GROWTH FACTOR; BISINDOLYLMALEIMIDE; CHYMASE; CHYMOSTATIN; COMPLEMENTARY DNA; COMPOUND 48-80; CURCUMIN; I KAPPA B; MESSENGER RNA; NEUTRALIZING ANTIBODY; PYRROLIDINE DITHIOCARBAMATE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANGIOTENSIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME MECHANISM; FIBROBLAST CULTURE; GRANULATION TISSUE; GRANULOMA; HAMSTER; IMMUNOMODULATION; INHIBITION KINETICS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CHYMASES; CRICETINAE; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GRANULOMA; HEMOGLOBINS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; P-METHOXY-N-METHYLPHENETHYLAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; SKIN; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036721506     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.034231     Document Type: Article

References (41)

1. Angiotensin II-induced angiogenesis in sponge implants in mice
2. Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations
3. Influence of the angiotensin system on endothelial cell and smooth muscle cell migration
4. Angiogenesis in inflammatory joint disease: A target for therapeutic intervention
5. Retinal and choroidal neovascularization
6. Angiogenesis in cancer and other diseases
7. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
8. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
9. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation
10. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR
11. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
12. Neovascularization produced by angiotensin II
13. Angiogenesis in cancer, vascular, rheumatoid and other disease
14. Comparative evaluation of angiogenesis assessment with anti-factor VIII and anti-CD31 immunostaining in non-small cell lung cancer
15. Angiogenic factors stimulate mast-cell migration
16. 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers
17. Angiogenesis: Implications for rheumatoid arthritis
18. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo
19. + exchange and stimulates growth in cultured vascular smooth muscle cells
20. Opposing actions of angiotensins on angiogenesis
21. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants
22. Chymase as a proangiogenic factor. A possible involvement of chymase- angiotensin -dependent pathway in the hamster sponge angiogenesis model
23. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas
24. Angiotensin II and retinal pericytes migration
25. The role of PECAM-1 in vascular cell biology
26. Marked species-difference in the vascular angiotensin II-forming pathways: Humans versus rodents
27. Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes
28. Angiotensin II -induced proliferation of aortic myocytes in spontaneously hypertensive rats
29. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells
30. Developmental platelet endothelial cell adhesion molecule expression suggests multiple roles for a vascular adhesion molecule
31. Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans
32. Human skin chymotryptic proteinase. Isolation and relation to cathepsin G and rat mast cell proteinase I
33. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit and characterization of transcriptional and posttranscriptional regulatory sequences
34. Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats
35. Neuronal apoptosis mediated by IL-1Β expression in viral encephalitis caused by a neuroadapted strain of the mumps virus (Kilham Strain) in hamsters
36. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
37. Inhibition of angiogenesis in Kaposi's sarcoma by captopril
38. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells
39. Host cyclooxygenase-2 modulates carcinoma growth
40. A human lung mast cell chymotrypsin-like enzyme. Identification and partial characterization
41. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: Possible role of the vascular endothelial growth factor